Rate Video

ESMO 2019 | Current challenges and key developments in CRC

Kai-Keen Shiu • 27 Sep 2019

Colorectal Cancer Gastrointestinal Cancer

Kai-Keen Shiu, FRCP, PhD, University College London Hospitals NHS Foundation Trust, London, UK, speaks to us about the key developments in colorectal cancer (CRC). Dr Shiu addresses the challenges and future directions in profiling and treating CRC. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

CUPISCO & GEFCAPI04: molecularly-guided therapy in cancer of unknown primary

Kai-Keen Shiu • 27 Sep 2019

KEYNOTE-177: final PFS analysis of pembrolizumab in patients with MSI-H/dMMR mCRC

Kai-Keen Shiu • 17 Jan 2021

Future prospects for treating rectal cancer

Kai-Keen Shiu • 14 Jun 2018

KEYNOTE-177 discussion: chemo-immunotherapy, pseudoprogression & biomarkers

Kai-Keen Shiu • 17 Jan 2021

Related Videos

Personalizing ctDNA analysis to predict CRC relapse

Gayathri Anandappa • 22 Jan 2021

Real-world outcomes of patients with intrahepatic CCA treated with trans-arterial radioembolization

Thomas Helmberger • 22 Jan 2021

Outcomes with multikinase inhibitors after progression on first-line atezolizumab-bevacizumab in HCC

Changhoon Yoo • 21 Jan 2021

Final results from ClarIDHy

Ghassan K. Abou-Alfa • 21 Jan 2021